A: This injectable medication is available through verified dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India, ensuring accessibility and authenticity.
Derived from a modified fragment of human growth hormone (HGH), AOD-9604 is specifically designed for targeted fat-related research without influencing growth hormone pathways linked to muscle development
Each capsule contains 50 mg of 5-Amino-1MQ , with 60 capsules per bottle , providing a standardized format suitable for controlled investigational and analytical research environments
Providers need reliable sourcing, pharmacy coordination, clear clinical guidance, and confidence in when newer compounds actually make sense for the patient sitting in front of them
Follow-up Repeat metabolic markers after 8-12 weeks if the protocol is being continued or adjusted
Development was ultimately discontinued after clinical results did not demonstrate sufficient efficacy to meet pharmaceutical thresholds